Related Experiment Video
Updated: Jan 17, 2026

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
8.0K
Modeling bistable dynamics arising from macrophage-tumor interactions in the tumor microenvironment
Hwayeon Ryu1, Susanna Röblitz2, Kamila Larripa3
1Department of Mathematics and Statistics, Elon University, Elon, NC, USA.
Mathematical Biosciences
|September 18, 2025
Summary
This study models tumor-associated macrophages (TAMs) and tumor growth, revealing bistability that enhances immunotherapy sensitivity. Mathematical insights guide strategies to reduce tumor burden by shifting macrophage phenotypes.
Area of Science:
- Immunology
- Mathematical Biology
- Computational Oncology
Background:
- Tumor-associated macrophages (TAMs) are crucial in the tumor microenvironment (TME), originating from monocytes.
- TAMs can adopt M1 (anti-tumor) or M2 (pro-tumor) phenotypes, significantly impacting tumor progression.
- Targeting TAMs offers therapeutic potential for cancer treatment.
Purpose of the Study:
- To develop a mathematical model of tumor volume dynamics and TAM populations (naïve, M1, M2, mixed).
- To investigate the bidirectional interplay between tumor growth and macrophage polarization.
- To identify conditions for enhanced immunotherapy response through system bistability.
Main Methods:
- Developed a mathematical model simulating tumor volume and TAM populations over time.
- Incorporated bidirectional feedback between tumor development and macrophage polarization.
- Utilized numerical simulations, bifurcation analysis, and global sensitivity analysis.
Main Results:
- The model demonstrated emergent bistability in tumor-macrophage dynamics.
- Bistability indicates increased system controllability, responsiveness to perturbations, and immunotherapy sensitivity.
- Identified key parameters influencing TME and tumor dynamics through sensitivity analysis.
Conclusions:
- Mathematical modeling reveals bistability as a critical factor for effective cancer immunotherapy.
- Understanding parameter-dependent bistability can guide treatment strategies to transition from high to low tumor burden.
- This approach provides insights for developing novel therapeutic interventions targeting TAMs.

